Sandbox gc3

Revision as of 20:54, 2 July 2020 by Gerald Chi (talk | contribs) (Created page with "{| style="border: 2px solid #4479BA; align="left" ! style="width: 800px; background: #4479BA;"|{{fontcolor|#FFF|Most Common Grade ≥3 Non-Serious Adverse Events}} ! style="wi...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Most Common Grade ≥3 Non-Serious Adverse Events Remdesivir Placebo
Anemia or decreased hemoglobin 43 (8%) 47 (9%)
Acute kidney injury, decreased eGFR or creatinine renal clearance, or increased blood creatinine 40 (7%) 38 (7%)
Pyrexia 27 (5%) 17 (3%)
Hyperglycemia or increased blood glucose 22 (4%) 17 (3%)
Increased transaminases, including ALT and/or AST 22 (4%) 31 (6%)
Retrieved from "https://www.wikidoc.org/index.php?title=Sandbox_gc3&oldid=1620861"